These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37354441)

  • 1. Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and
    Yan Y; Qu S; Liu J; Li C; Yan X; Xu Z; Qin T; Jia Y; Pan L; Gao Q; Jiao M; Li B; Gale RP; Xiao Z
    Leuk Lymphoma; 2023 Sep; 64(9):1605-1610. PubMed ID: 37354441
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
    Verstovsek S; Subbiah V; Masarova L; Yin CC; Tang G; Manshouri T; Asatiani E; Daver NG
    Ann Oncol; 2018 Aug; 29(8):1880-1882. PubMed ID: 29767670
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
    Fan XS; Wang SA
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.
    Wang B; Wang X; Lin J; Zhang Y; Gan W; Li T
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30507. PubMed ID: 37336772
    [No Abstract]   [Full Text] [Related]  

  • 6. Myeloid/lymphoid neoplasm with FGFR1 rearrangement.
    Germans SK; Chen M
    Blood; 2021 Sep; 138(10):912. PubMed ID: 34499152
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission.
    Sugiyama M; Arakawa A; Kogure Y; Shirakawa N; Watanabe M; Ito Y; Tanimura K; Tao K; Nakajima M; Watanabe Y; Miyagi-Maeshima A; Fukuhara S; Kataoka K; Izutsu K; Fukuda T; Ogawa C
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30721. PubMed ID: 37833848
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
    Loscocco GG; Ascani S; Mannelli F; Zanelli M; Rotunno G; Santi R; Vannucchi AM
    Am J Hematol; 2023 Dec; 98(12):1959-1962. PubMed ID: 37435901
    [No Abstract]   [Full Text] [Related]  

  • 10. Myeloid/lymphoid neoplasm with a novel cryptic
    Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
    Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
    Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The power of the partner: defying expectations in a case of a myeloproliferative neoplasm with FGFR1 rearrangement.
    Wilberger AC; McMahon B; Ewalt MD
    Leuk Lymphoma; 2019 Apr; 60(4):1095-1097. PubMed ID: 30277124
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
    Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
    Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
    Li W; Cooley LD
    Blood; 2016 Sep; 128(10):1440. PubMed ID: 27769039
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
    Duckworth CB; Zhang L; Li S
    Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].
    Liu YT; Zhao JW; Feng J; Li QH; Chen YM; Qiu LG; Xiao ZJ; Li Y; Gong BF; Gong XY; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):848-852. PubMed ID: 31775485
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
    Rathe M; Kristensen TK; Møller MB; Carlsen NL
    Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.